Cargando…

A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Li, Lan-Zhu, Sun, Qian, Fang, Yu, Yang, Li-Jia, Xu, Zi-Yao, Hu, Jin-Hua, Cao, Lan, Huang, Jia-Yu, Hong, Ming, Li, Jian-Yong, Qian, Si-Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462201/
https://www.ncbi.nlm.nih.gov/pubmed/32826471
http://dx.doi.org/10.1097/CM9.0000000000000962
_version_ 1783576869447139328
author Li, Lan-Zhu
Sun, Qian
Fang, Yu
Yang, Li-Jia
Xu, Zi-Yao
Hu, Jin-Hua
Cao, Lan
Huang, Jia-Yu
Hong, Ming
Li, Jian-Yong
Qian, Si-Xuan
author_facet Li, Lan-Zhu
Sun, Qian
Fang, Yu
Yang, Li-Jia
Xu, Zi-Yao
Hu, Jin-Hua
Cao, Lan
Huang, Jia-Yu
Hong, Ming
Li, Jian-Yong
Qian, Si-Xuan
author_sort Li, Lan-Zhu
collection PubMed
description
format Online
Article
Text
id pubmed-7462201
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-74622012020-09-16 A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia Li, Lan-Zhu Sun, Qian Fang, Yu Yang, Li-Jia Xu, Zi-Yao Hu, Jin-Hua Cao, Lan Huang, Jia-Yu Hong, Ming Li, Jian-Yong Qian, Si-Xuan Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2020-08-20 2020-08-05 /pmc/articles/PMC7462201/ /pubmed/32826471 http://dx.doi.org/10.1097/CM9.0000000000000962 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Correspondence
Li, Lan-Zhu
Sun, Qian
Fang, Yu
Yang, Li-Jia
Xu, Zi-Yao
Hu, Jin-Hua
Cao, Lan
Huang, Jia-Yu
Hong, Ming
Li, Jian-Yong
Qian, Si-Xuan
A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
title A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
title_full A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
title_fullStr A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
title_full_unstemmed A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
title_short A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
title_sort report on lineage switch at relapse of cd19 car-t therapy for philadelphia chromosome-positive b-precursor acute lymphoblastic leukemia
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462201/
https://www.ncbi.nlm.nih.gov/pubmed/32826471
http://dx.doi.org/10.1097/CM9.0000000000000962
work_keys_str_mv AT lilanzhu areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT sunqian areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT fangyu areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT yanglijia areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT xuziyao areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT hujinhua areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT caolan areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT huangjiayu areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT hongming areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT lijianyong areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT qiansixuan areportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT lilanzhu reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT sunqian reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT fangyu reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT yanglijia reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT xuziyao reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT hujinhua reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT caolan reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT huangjiayu reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT hongming reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT lijianyong reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia
AT qiansixuan reportonlineageswitchatrelapseofcd19carttherapyforphiladelphiachromosomepositivebprecursoracutelymphoblasticleukemia